Lyme disease in Belgium.
A sero-epidemiological clinical and risk-group study was performed in Belgian Military men with a home-made Elisa kit, with the N34 Bb strain kindly provided by Prof. Ackermann Cologne. In the sero-epidemiological group the seroprevalence (age 18-28 years) was 3.2% In the clinical group the results were correlating to the serological and clinical data. In the risk group 44% were IgG positive. In conclusion the exposure of a standard Belgian young male population is low. (Overall IgG seropositivity 3.2%) (Total N = 1,916).
Clement
J
J
Belgian Military Hospitals, Brussels.
Wouters
R
R
Lefevre
A
A
Hertens
M
M
Ramon
A
A
Ackermann
R
R
D000293:Adolescent; D000328:Adult; D001530:Belgium / Q000453:epidemiology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008193:Lyme Disease / Q000453:epidemiology*; D008297:Male; D008889:Military Personnel; D012307:Risk Factors; D016036:Seroepidemiologic Studies